WCG CenterWatch Reveals Results of its Global Clinical Trial Relationships Survey
WCG™, a provider of clinical trial solutions, today released highlights from its 2021 CenterWatch Global Site Relationship Benchmark Survey. The results show how more than 3,700 representatives from clinical trial sites around the world rate their sponsor and clinical research organization (CRO) relationships and their partners' responses to the COVID-19 pandemic.
Site respondents were asked to rank the overall reputation of 53 sponsors and 29 CROs and rate the relative importance of performance related attributes. They were then requested to identify the organizations they had worked with most during the past two years and rate those organization's performance against the attributes.
WCG CenterWatch included the same performance attributes in its 2017, 2019, and 2021 surveys so that comparisons can be made between those results, and trends evaluated. An in-depth report, which includes the 2021 sponsor and CRO rankings, is available for additional analysis here.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
